Login to Your Account



Gamesmanship has to stop, Rx drug companies told

By Mari Serebrov
Regulatory Editor

Wednesday, November 8, 2017

"End the shenanigans," FDA Commissioner Scott Gottlieb told brand drug manufacturers Wednesday as the Federal Trade Commission (FTC) opened a workshop looking at the obstacles to robust competition in the U.S. prescription drug market.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription